Correction: Beneficial role of rosuvastatin in blood–brain barrier damage following experimental ischemic stroke
Frontiers in Pharmacology · 26.06.2026 · 17
DOI: 10.3389/fphar.2026.1895293 ↗Kurz gefasst
Korrektur in der Zeitschrift Frontiers in Pharmacology, online erschienen am 26.06.2026. Verfasst von Dan Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Stroke Center, The First Affiliated Hospital, Jinan University, Guangzhou, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology and Stroke Center, The First Affiliated Hospital, Jinan University, Guangzhou, China.
- Clinical Neuroscience Institute of Jinan University, Jinan University, Guangzhou, China.
Zitieren
APA
Lu, D., Mai, H. C., Liang, Y. B., Xu, B. D., Xu, A. D., & Zhang, Y. S. (2026). Correction: Beneficial role of rosuvastatin in blood–brain barrier damage following experimental ischemic stroke. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1895293
Vancouver
Lu D, Mai HC, Liang YB, Xu BD, Xu AD, Zhang YS. Correction: Beneficial role of rosuvastatin in blood–brain barrier damage following experimental ischemic stroke. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1895293
BibTeX
@article{Lu2026,
author = {Lu, Dan and Mai, Hong-Cheng and Liang, Yu-Bin and Xu, Bing-Dong and Xu, An-Ding and Zhang, Yu-Sheng},
title = {Correction: Beneficial role of rosuvastatin in blood–brain barrier damage following experimental ischemic stroke},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1895293}
}
EUVIMED